What question did this study set out to answer?

Evaluate behavioral changes, HIV seroprevalence trends, and the spectrum of disease burden among intravenous drug users.

January 1, 1988AIDS

HIV and intravenous drug use

View Full Paper

Ask AI

Bookmark

Authors

DJDon C. Des JarlaisLaGuardia Community College SFSamuel R. FriedmanUniversity of New Haven

Discussion

Member takes

Implication

Epidemiological review reveals substantial injection risk reduction alongside stable seroprevalence among intravenous drug users, indicating urgent need for broader prevention models.

Key Points

Evaluate behavioral changes, HIV seroprevalence trends, and the spectrum of disease burden among intravenous drug users.
Synthesized epidemiological data and surveillance reports across diverse geographic areas regarding risk behaviors and HIV transmission among intravenous drug users.
Observed widespread reductions in injection risk practices correlating with relative stabilization of HIV seroprevalence rates across multiple geographic areas.
Identified that modifying sexual risk behavior remains substantially more difficult than altering injection practices among drug users.
Documented a broader spectrum of HIV-related morbidity and mortality than captured by standard AIDS surveillance definitions.

Cite This Study

Jarlais et al. (1988) studied this question.

synapsesocial.com/papers/6a83dc4b07bf35307a996f9e https://doi.org/10.1097/00002030-198800001-00010

View Full Paper

Ask AI

Bookmark

Implication

Epidemiological review reveals substantial injection risk reduction alongside stable seroprevalence among intravenous drug users, indicating urgent need for broader prevention models.

HIV and intravenous drug use

Discussion

Member takes

Implication

Key Points

Cite This Study

HIV and intravenous drug use

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider